{
    "code": 0,
    "data": [
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Litigation",
            "news_body": "Update on litigation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac56a368-3a5d-424f-a2c9-1027c69a1eba.pdf",
            "news_date": "2026-02-12 08:26:38"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Link",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da91007-b524-47eb-b54e-66b7f1e6b3c7.pdf",
            "news_date": "2026-02-10 17:52:53"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper cutting with regard to publication of unaudited financial results for the quarter / nine months ended on December 31 2025 in Financial Express on February 10 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66f6eaba-323c-40f7-a309-69855e425f4e.pdf",
            "news_date": "2026-02-10 12:39:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on unaudited Financial Results for the quarter and nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74af5e57-0cbb-40f4-ad26-6c151107fc4a.pdf",
            "news_date": "2026-02-09 13:30:13"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on unaudited financial results for the quarter and nine months ended on December 31 2025",
            "news_id": "55eca7e4-1af3-4e2d-9606-f06c573f19bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92fec597-5665-48a4-b102-1872064c91e8.pdf",
            "news_date": "2026-02-09 13:26:37",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on unaudited financial results for the quarter and nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92fec597-5665-48a4-b102-1872064c91e8.pdf",
            "news_date": "2026-02-09 13:26:37"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Board Comments On Penalties Levied By BSE And NSE",
            "news_body": "Board comments on penalties levied by BSE and NSE",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=beedd68e-f5ac-4a94-b895-117a22cbc541.pdf",
            "news_date": "2026-02-09 13:24:21"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "Unaudited Financial results for the quarter and nine months ended on December 31 2025",
            "news_id": "acf48f92-9c4e-4a19-928b-4f90bce6330e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc2412e0-cb5c-4382-9573-2a55aa55db7f.pdf",
            "news_date": "2026-02-09 13:22:59",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "Unaudited Financial results for the quarter and nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc2412e0-cb5c-4382-9573-2a55aa55db7f.pdf",
            "news_date": "2026-02-09 13:22:59"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d7ba412-82c5-46b9-8388-6a5c8eb44951.pdf",
            "news_date": "2026-02-09 13:19:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of Sickle Cell Disease.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fa6462c-b80a-46ef-a0a2-e32c3743044a.pdf",
            "news_date": "2026-02-06 12:21:37"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets 5 mg and 10 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc501d1e-1b8a-4a32-aa92-3ff292ccccab.pdf",
            "news_date": "2026-02-04 14:40:56"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investor Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cefe8059-8106-4a04-976b-0ee7c2932bad.pdf",
            "news_date": "2026-02-04 10:17:47"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Superannuation of Senior Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f663943c-ed78-4e85-8c49-ff16b11bab73.pdf",
            "news_date": "2026-01-31 18:25:54"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Analyst Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12c3433e-7a57-4478-91e4-fc0cb70f708f.pdf",
            "news_date": "2026-01-30 12:57:56"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Nine Months Ended On December 31 2025.",
            "news_body": "Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Unaudited Financial Results for the quarter / nine months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87cb6356-51ea-40fa-beb9-086c8af9b60d.pdf",
            "news_date": "2026-01-27 16:42:10"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Outcome of USFDA inspection",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402d801b-556c-402c-9755-d13456e654c4.pdf",
            "news_date": "2026-01-23 17:42:19"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus launches the worlds first biosimilar of Nivolumab Tishtha in India to treat multiple cancers.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe3f4c5-ce99-42ea-92dc-cc210599f7a4.pdf",
            "news_date": "2026-01-22 09:54:33"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revision In ESG Rating",
            "news_body": "Revision in ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e809f71a-07bb-424c-95ed-8019d281200b.pdf",
            "news_date": "2026-01-20 10:38:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update",
            "news_body": "Dissolution of wholly owned subsidiary of Zydus MedTech (France) S.A.S. which is a step down wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4152269-a6d4-4485-935d-7cbf30c1e903.pdf",
            "news_date": "2026-01-17 17:54:38"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Closing Of Acquisition",
            "news_body": "Closing of acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1a9748f-cf01-476b-aad5-d9a773a09fb6.pdf",
            "news_date": "2026-01-15 17:30:09"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14a980c1-fb7e-4509-baaa-8e6c99aff58a.pdf",
            "news_date": "2026-01-15 13:14:17"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO (copper histidinate)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c1d9593-0b6a-425d-8d26-a2887eb6db53.pdf",
            "news_date": "2026-01-13 10:04:40"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update",
            "news_body": "Dissolution of a wholly owned subsidiary of Zydus MedTech (France) S.A.S. which is a step down wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e44cb0c-3e1e-43bf-8891-1966f37f1639.pdf",
            "news_date": "2026-01-10 14:16:37"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9201ba45-1d7b-47cb-a76b-731e4a82c347.pdf",
            "news_date": "2026-01-07 15:09:32"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Updates",
            "news_body": "Dissolution of a wholly owned subsidiary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b87c3be-c2bf-46d3-a22b-bec5a929728c.pdf",
            "news_date": "2026-01-02 14:36:47"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of Demand Order-In-Original From Assistant Commissioner Of State Tax Gujarat",
            "news_body": "Receipt of demand Order-In-Original from Assistant Commissioner of State Tax Gujarat",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2464ccfd-d41d-41dd-ab0b-ca34826f9a67.pdf",
            "news_date": "2025-12-30 18:29:53"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication regarding opening of a special window for re-lodgement of transfer requests for physical shares in accordance with SEBI Circular dated July 2 2025 published in the Financial Express English and Gujarati editions both on December 27 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4366e13a-61bf-492a-a474-9ca1fa4f30e2.pdf",
            "news_date": "2025-12-27 14:51:21"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of ESG Rating",
            "news_body": "Intimation of ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=653686bd-b92f-42fa-840b-b9b4d3ac3d23.pdf",
            "news_date": "2025-12-26 19:13:48"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of trading window closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cf47d01-8389-4c43-82a7-ed7e2401b34f.pdf",
            "news_date": "2025-12-26 18:52:13"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on December 26 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ec1e7d9-5b35-45ef-b920-8383a6fb6a73.pdf",
            "news_date": "2025-12-26 12:46:14"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update on acquisition of API business",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69ecb541-bbd5-4053-8048-29a077246792.pdf",
            "news_date": "2025-12-24 17:57:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO an Interchangeable Biosimilar to Lucentis. NUFYMCO BLA has been approved by the USFDA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec044ee9-b130-4bb2-a38f-a94bc171e606.pdf",
            "news_date": "2025-12-23 18:28:41"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f4a990-8146-494d-92d8-ace47ebe649c.pdf",
            "news_date": "2025-12-19 09:52:13"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of ESG Rating",
            "news_body": "Intimation of ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e73c31e-ad37-4f51-9636-79dd735f0852.pdf",
            "news_date": "2025-12-16 17:22:29"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eda760d-be98-4eae-96e3-b13c1d25cd72.pdf",
            "news_date": "2025-12-15 18:30:28"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Minutes of the postal ballot exercise of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e07b544-b839-4939-bb2e-1df70924c12a.pdf",
            "news_date": "2025-12-12 21:35:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Scrutinizers report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35f99517-fe98-4c5b-92a6-20fe4ba487fa.pdf",
            "news_date": "2025-12-12 21:33:08"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Disclosure of results under regulation 44(3) of SEBI (LODR) Reg 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aefa3404-52c4-4863-819d-0c3a6f286aa1.pdf",
            "news_date": "2025-12-12 21:30:01"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus launches biosimilar Denosumab 120 mg SC - protecting bone health in cancer patients.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1246e978-664d-4483-a46a-1f126463769e.pdf",
            "news_date": "2025-12-10 10:18:09"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in US and Canada.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18410988-f42d-46fa-8723-294a87b5f317.pdf",
            "news_date": "2025-12-09 17:31:08"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives EIR for the injectable facility located at Jarod.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a66c68d-02b4-4998-8665-ff25f551ed4f.pdf",
            "news_date": "2025-12-04 12:47:08"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets 10 mg/5 mg and 25 mg/5 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=650a9042-0a22-4b57-9e9f-cc9bccf97739.pdf",
            "news_date": "2025-11-27 16:31:31"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35617620-96cd-4bca-9d3e-b9feec6fb505.pdf",
            "news_date": "2025-11-26 12:27:25"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP 120 mg 180 mg and 240 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8ae0a23-903b-4403-afbd-e0db80aa524e.pdf",
            "news_date": "2025-11-25 15:58:36"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Corporate presentation",
            "news_id": "0e9d586f-97b4-4614-98e7-26b9a46b285b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca929d3-bed6-476d-9375-7f85bf065af3.pdf",
            "news_date": "2025-11-25 11:19:34",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Corporate presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca929d3-bed6-476d-9375-7f85bf065af3.pdf",
            "news_date": "2025-11-25 11:19:34"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on November 22 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09254bca-6484-4a84-862a-9010f02e3e11.pdf",
            "news_date": "2025-11-22 14:09:33"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Update",
            "news_body": "General update",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5804546f-be94-4efb-a9f1-ff0198ca4473.pdf",
            "news_date": "2025-11-19 16:41:47"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on November 18 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49108af5-44ef-4152-ada4-304172b94a89.pdf",
            "news_date": "2025-11-18 12:10:34"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under SEBI (Prohibition Of Insider Trading) Regulations 2015",
            "news_body": "Disclosure under SEBI (Prohibition of Insider Trading) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64eb0dbb-9110-492e-8247-6653792ce2ab.pdf",
            "news_date": "2025-11-17 19:07:39"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on November 14 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd87e074-2fed-4562-b83d-f0efa99221d6.pdf",
            "news_date": "2025-11-14 13:57:26"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives final approval from USFDA for Leuprolide Acetate injection 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c3cb9ff-5c32-4ca5-aa6c-ee0b86060295.pdf",
            "news_date": "2025-11-14 13:45:52"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Closure of USFDA inspection at Zydus oncology injectable manufacturing facility in SEZ1 Ahmedabad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0a5d75e-bbc0-429f-99e8-2819778f560d.pdf",
            "news_date": "2025-11-13 19:03:48"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Revised press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a602b61c-acaf-4da1-9645-3245c799520e.pdf",
            "news_date": "2025-11-13 16:44:58"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules 231 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=394df45b-5461-4c64-ba09-d8a0e424310f.pdf",
            "news_date": "2025-11-13 13:56:58"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus Amplitude receives CE mark for its robotic surgical system Andy.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1dddec2-e6e1-4036-b4cc-a14185e47864.pdf",
            "news_date": "2025-11-13 12:43:47"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on November 6 2025",
            "news_id": "1a11e0ce-92fa-41f9-b546-cf40b16fcc5b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ee65b8-585c-48b6-b9d6-a568f7c30851.pdf",
            "news_date": "2025-11-13 11:19:49",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on November 6 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ee65b8-585c-48b6-b9d6-a568f7c30851.pdf",
            "news_date": "2025-11-13 11:19:49"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ee9ffd-f581-4a9f-a56b-93042e2ae4f3.pdf",
            "news_date": "2025-11-12 16:07:05"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99ca079f-3b53-4620-9364-af28703be734.pdf",
            "news_date": "2025-11-11 11:15:54"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives approval from Chinas NMPA for Venlafaxine Extended-Release Capsules 75 mg and 150 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=685ed8e7-632b-4296-bf22-41801c2436f0.pdf",
            "news_date": "2025-11-11 09:56:26"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives tentative approval from USFDA for Olaparib Tablets 100 mg and 150 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92a4ac68-e8d7-4988-84ea-fb3169945d47.pdf",
            "news_date": "2025-11-07 18:01:21"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of newspaper cutting with regard to publication of unaudited financial results for the quarter / half year ended on September 30 2025 in Financial Express on November 7 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b3add29-0d75-4063-8b83-e4b155c130f6.pdf",
            "news_date": "2025-11-07 11:42:10"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio link",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f354435-b7af-4938-a564-e7dc58e6f65b.pdf",
            "news_date": "2025-11-06 18:56:50"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "23b69f25-7e29-4866-952a-74d5b30da1ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e6336b-5e24-4d76-95fa-eff0c21897c7.pdf",
            "news_date": "2025-11-06 13:20:17",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e6336b-5e24-4d76-95fa-eff0c21897c7.pdf",
            "news_date": "2025-11-06 13:20:17"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c732a0e7-09b7-4cd8-b23b-6ca8748c207e.pdf",
            "news_date": "2025-11-06 13:14:08"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Raising of Funds",
            "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08d81ff1-c19f-4c91-8ae1-dce89152879c.pdf",
            "news_date": "2025-11-06 13:12:21"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21e635df-6ca2-4b3f-a173-5b94daea6cf1.pdf",
            "news_date": "2025-11-06 13:10:18"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Unaudited financial results for the quarter and half year ended on September 30 2025",
            "news_id": "36687bb5-4dc9-48b3-a101-560068711da2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73b2ed31-9bed-4ea4-9cd7-de491505f382.pdf",
            "news_date": "2025-11-06 13:03:59",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Unaudited financial results for the quarter and half year ended on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73b2ed31-9bed-4ea4-9cd7-de491505f382.pdf",
            "news_date": "2025-11-06 13:03:59"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab856262-f782-4d20-a2fd-e31ccfee02c0.pdf",
            "news_date": "2025-11-06 09:55:51"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives EIR for SEZ II manufacturing facility Ahmedabad.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd752062-56c4-4e62-af39-79311f23749f.pdf",
            "news_date": "2025-11-05 11:16:10"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives tentative approval from USFDA for Budesonide delayed release capsules 4 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59aef5be-3768-4e32-a20c-671fbfdd897e.pdf",
            "news_date": "2025-11-04 14:39:06"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Update on board meeting",
            "news_body": "Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve To consider fund raising",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c27b8f9-b62b-47cc-99d5-17120704a9dc.pdf",
            "news_date": "2025-11-03 17:27:23"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Demand Notice From GST Department",
            "news_body": "Demand Notice from GST Department",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07176047-7eb7-46f4-ad8a-426beb005a36.pdf",
            "news_date": "2025-11-01 11:06:04"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Q2 FY26 post results earning call details",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=534b4a27-be76-4100-8124-50680e01cfba.pdf",
            "news_date": "2025-10-29 18:54:36"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives EIR for the Baddi manufacturing facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9449c8dc-a489-4ee6-a85a-563ee9caa464.pdf",
            "news_date": "2025-10-29 18:28:54"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Half Year Ended On September 30 2025.",
            "news_body": "Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve unaudited financial results for the quarter / half year ended on September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c03be1f-3380-4163-bc5f-a180cdb5e396.pdf",
            "news_date": "2025-10-29 12:23:24"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Closing of Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2e32446-750d-439c-919b-cb2c08aeebb5.pdf",
            "news_date": "2025-10-26 11:51:31"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56c97b49-f55c-4f5c-9089-d5c2e863db4d.pdf",
            "news_date": "2025-10-24 19:25:24"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update",
            "news_body": "Update",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d81557ea-e634-4f9c-9c15-55a780e83600.pdf",
            "news_date": "2025-10-17 11:19:27"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea26c34b-0575-4970-9d67-a016683c3ac7.pdf",
            "news_date": "2025-10-14 10:26:41"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in Financial Express English and Gujarati editions both on October 9 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=737c261a-46fc-43a5-9ad7-00f2304a04f4.pdf",
            "news_date": "2025-10-09 13:45:36"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee308335-92b9-40de-b895-33b1174606a1.pdf",
            "news_date": "2025-10-06 16:25:02"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus receives final approval from USFDA for Deflazacort oral suspension 22.75 mg/mL.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=902e3cec-8cc0-49c5-b610-261e526bebfe.pdf",
            "news_date": "2025-10-06 15:04:56"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati editions both on October 4 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=943d9c07-843f-4380-bcf0-2f56b6cbcba0.pdf",
            "news_date": "2025-10-04 11:49:16"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sentynl Therapeutics updates on its NDA for CUTX-101",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acd1b21e-6d61-4f42-aa95-0912defb21ce.pdf",
            "news_date": "2025-10-01 17:52:00"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update on acquisition of API business",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5576d65-d675-411e-9110-e7222654854f.pdf",
            "news_date": "2025-09-30 16:34:19"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44c6a824-1c9b-436c-a348-ecc3e2995443.pdf",
            "news_date": "2025-09-27 18:30:04"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of Order From Commissioner Of CGST Ahmedabad",
            "news_body": "Receipt of order from Commissioner of CGST Ahmedabad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b563e1a-57b4-4af2-a93d-d614786d1da9.pdf",
            "news_date": "2025-09-25 15:49:20"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Transcript Of The 30Th Annual General Meeting",
            "news_body": "Transcript of the 30th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd133ed5-4221-4684-b571-57ce8e92ffae.pdf",
            "news_date": "2025-09-24 10:34:10"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f709185-d88d-4147-851c-62b10dc6a480.pdf",
            "news_date": "2025-09-23 12:15:20"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a611d10-db92-48cc-9de3-0a549dc8d9f6.pdf",
            "news_date": "2025-09-21 08:46:02"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "The Company is going to participate in 10th Annual J. P. Morgan India Conference at Mumbai on September 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a8dee5d-00ef-441e-8e35-c9a5d54800fe.pdf",
            "news_date": "2025-09-16 18:25:56"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Releases",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7841e1f4-2b04-408c-a103-8d2555f15515.pdf",
            "news_date": "2025-09-15 18:56:10"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "The newspaper publication of notice of 100 days Campaign - Saksham Niveshak published in the Financial Express English and Gujarati editions both on September 13 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ded641c-05a8-46a9-aab2-48426a6c072e.pdf",
            "news_date": "2025-09-13 14:04:33"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Closure of USFDA inspection at Zydus injectable manufacturing plant at Jarod.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ebfc89b-b192-4050-bd2e-e1f1aa34b304.pdf",
            "news_date": "2025-09-05 19:31:43"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Senior Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f3ea9d0-936c-49e3-a4e1-27dcd5ae9c87.pdf",
            "news_date": "2025-09-05 09:45:16"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA) for the US market.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7ff972d-39d3-4359-bcd6-4b7fee93a359.pdf",
            "news_date": "2025-09-04 15:52:45"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d5da51d-80b1-46ff-84a9-89035f80426e.pdf",
            "news_date": "2025-09-02 12:01:03"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48ca89a0-3d3c-4210-9180-d595c68ecf35.pdf",
            "news_date": "2025-08-29 10:52:28"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in senior management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91c0d08b-0eec-44d7-b095-f8e75bfa2ff0.pdf",
            "news_date": "2025-08-26 16:20:37"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of ESG Rating",
            "news_body": "Intimation of ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e5d6a9e-e57f-4aaf-b8f1-4a6710987328.pdf",
            "news_date": "2025-08-26 11:21:51"
        },
        {
            "co_code": 20883,
            "bse_code": 532321,
            "isin": "INE010B01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati Editions both on August 20 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf3d3100-d1f7-4bb9-a1d5-166acc631575.pdf",
            "news_date": "2025-08-20 16:25:21"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on August 12 2025",
            "news_id": "d96d9c49-14ef-42ca-baa1-4e13faba26ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64106ebe-0cb5-444a-a148-82e2be083189.pdf",
            "news_date": "2025-08-20 11:14:57",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "1091ad92-dd0f-47c4-8e7d-083ffdaa98d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dde79516-6d2a-4c21-8cbf-5b4ca26d5757.pdf",
            "news_date": "2025-08-12 13:06:15",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited financila results for the quarter ended on June 30 2025",
            "news_id": "3e8246cb-da11-4dc3-9484-cdeb0b6b2840",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cbe5847-8d21-4622-bb0d-ead46665c984.pdf",
            "news_date": "2025-08-12 13:03:52",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Investor presentation to be made during the investors conference to be held between June 25 2025 to June 27 2025.",
            "news_id": "fe35c3d4-57bf-4083-a7cf-83a5a1d82aaa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1edbdced-39a6-4e2a-bde6-ab204a1e9fce.pdf",
            "news_date": "2025-06-24 17:50:15",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on May 20 2025",
            "news_id": "c2686702-f90e-4297-b472-62ee3925f12f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0de3fb26-4e76-407a-a262-86ec5dd2d679.pdf",
            "news_date": "2025-05-27 09:37:11",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Companys Investor Call discussing about the audited financial results for the quarter / year ended on March 31 2025.",
            "news_id": "b538ee21-57f5-4a81-a010-acccb6421390",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a323a1b1-f497-4d85-9309-ed43539d6bd0.pdf",
            "news_date": "2025-05-20 19:41:03",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "273a5339-d3a4-4676-9fbe-2dcc5776cac4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbecbf9a-ccab-46b9-a3d3-616d25ae192c.pdf",
            "news_date": "2025-05-20 13:19:58",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Audited Financial Results",
            "news_id": "e9188251-ef7f-42e5-9ac1-98baeb9b1453",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=699a56d9-61b0-4fb6-962f-e10183158e5d.pdf",
            "news_date": "2025-05-20 13:07:59",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "c963874e-d7f7-4c3f-9855-21c850487b41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68f014ea-1cdc-4fac-9ab2-9bde643b02f4.pdf",
            "news_date": "2025-03-11 17:03:12",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on February 5 2025",
            "news_id": "91fee31c-4fec-48ed-a0af-136b168a5030",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb347feb-4cf6-46f4-bc94-a2aefdf62f40.pdf",
            "news_date": "2025-02-11 18:28:59",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "ca3fbb29-d7a9-41e8-a54b-7f2f155165d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd0c7209-6344-49f3-93dd-73d87952cc05.pdf",
            "news_date": "2025-02-05 12:30:57",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Nine Months Ended On December 31 2024",
            "news_body": "Unaudited financial results for the quarter / nine months ended on December 31 2024",
            "news_id": "e4d39360-5049-4a80-879e-ed9875eb19b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13538fd1-3a87-4f49-9ba0-df233f4a4da8.pdf",
            "news_date": "2025-02-05 12:24:10",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the Company's Investor Call discussing about the unaudited financial results for the quarter / half year ended September 30, 2024",
            "news_id": "7dbc1894-c6b4-4ab4-96a8-8b0d5cb041a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f4b32b1-8e5e-4e07-a3c9-39350dc6455c.pdf",
            "news_date": "2024-11-12 21:50:04",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for the quarter / half year ended on September 30, 2024",
            "news_id": "f46b5e26-8f81-4e0a-aece-a79d04878471",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52e2caf2-09d0-4382-af9f-5986a8af322d.pdf",
            "news_date": "2024-11-12 12:40:31",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2024",
            "news_body": "Unaudited financial results for the quarter and half year ended on September 30, 2024",
            "news_id": "a35153fd-e3ff-48d3-b5a2-2049fcf18595",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=086a00ba-0aa7-4597-89a2-0f89668284ed.pdf",
            "news_date": "2024-11-12 12:35:28",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "905f1d57-c87a-4c00-bfaf-d3cb44faf8ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bc7cf3-4d64-41b0-b59a-57a32aebf962.pdf",
            "news_date": "2024-08-27 11:25:53",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "60a6d55f-32c8-43da-8b84-98491bd44f25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=627201e5-f8e2-47e4-b3b9-edd3b9196644.pdf",
            "news_date": "2024-08-09 13:02:22",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited Financial results for the quarter ended June 30, 2024",
            "news_id": "2293574e-e713-4586-9ae6-9250b869e9e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d269cacb-be0f-4859-a23f-9ae12cfda88e.pdf",
            "news_date": "2024-08-09 12:55:33",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the post results earnings call held on May 17, 2024",
            "news_id": "d8cc647a-8078-4d27-8755-1ef96090192e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25c0da34-3a35-48a8-9d1e-2d010f73d3ee.pdf",
            "news_date": "2024-05-23 15:36:49",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "33c3e4f1-c9ec-48b8-8e68-1d3417d38121",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=169310c7-f0ae-45e8-b268-ff626a963ba9.pdf",
            "news_date": "2024-05-17 15:49:13",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended On March 31, 2024",
            "news_body": "Audited financial results for the quarter and year ended on March 31, 2024",
            "news_id": "b2e0ea48-4058-4b44-954f-6f625f564af5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e2b3906-d4da-47c4-8ea5-4a08521b0b43.pdf",
            "news_date": "2024-05-17 15:40:02",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Post Results Earnings Call held on February 9, 2024",
            "news_id": "83084688-4999-46be-b749-0df0fe15e35e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ada2c19e-6f22-48d8-97c6-93331b5bc851.pdf",
            "news_date": "2024-02-14 16:11:48",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "c23a1d7d-5b6d-4480-a416-c7c9b0984db2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0788f62-f199-48e8-aafa-70ec911ee1a1.pdf",
            "news_date": "2024-02-09 13:10:25",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023",
            "news_body": "Unaudited financial results for the quarter and nine months ended on December 31, 2023",
            "news_id": "6efb2cd3-dd88-43bb-be78-74df45b08f72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba078a19-84ca-432a-a165-a7ab62d00f2c.pdf",
            "news_date": "2024-02-09 12:56:21",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call Q2 FY24",
            "news_id": "83f35dfb-43e5-4472-bddf-a9cfbc727f91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09ef84d9-f00a-4a59-a65c-dfc08c6a8f2c.pdf",
            "news_date": "2023-11-11 16:27:02",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on the unaudited financial results for the quarter / half year ended on September 30, 2023",
            "news_id": "6a001ea1-ebc1-442d-a56b-5b751e36b11b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f97e66be-f445-4da9-8fe4-743f0fcb4068.pdf",
            "news_date": "2023-11-07 12:06:40",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter / half year ended on September 30, 2023",
            "news_id": "38e9c1dc-167d-499f-86a2-3ae5c6e29a98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fde7ccfb-b996-4365-a1d5-adb45893c7e9.pdf",
            "news_date": "2023-11-07 12:01:20",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "98ece71a-e6a1-4c35-ad46-665a4cef5e0f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9149c8f-f914-4481-894f-b1f2ecfe25dc.pdf",
            "news_date": "2023-09-17 19:41:00",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call",
            "news_id": "45c1e569-2371-40c4-b3f5-06a546fd649c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4e2412e-5014-4fad-a445-9f1dbb9b6a68.pdf",
            "news_date": "2023-08-18 09:25:25",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2023",
            "news_id": "25ba3d88-de11-4892-8c36-f23a15951a3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2c38444-6a6e-466d-9fd8-3521cfe9f294.pdf",
            "news_date": "2023-08-11 12:36:08",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended On June 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended on June 30, 2023",
            "news_id": "b28f2a85-1752-40d0-a29d-a1d2ed907e73",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15488ad8-b534-4a39-911d-12c8adf14de1.pdf",
            "news_date": "2023-08-11 12:31:39",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Post Results Earnings Call held on May 18, 2023",
            "news_id": "43ccfe04-78fa-4d73-a6ee-902d9263f896",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d51e91a-d8c2-4c4c-8cba-793347efe82a.pdf",
            "news_date": "2023-05-24 18:03:46",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provisions of regulations 30 and 46(2)(oa) of the Listing Regulations, we hereby inform that the audio recording of the Company's Investor Call discussing about the financial results for the quarter / year ended March 31, 2023 is available on the Company's website.",
            "news_id": "35275f89-2d80-40d7-b9c9-b4926fe3ed4a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cc617a2-e402-47b3-b416-2be2f370aeaa.pdf",
            "news_date": "2023-05-18 19:50:55",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "7d429ec5-8a71-4e83-8c10-6edea30a2708",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78a7525d-ad97-4928-952a-ea2a73371ab5.pdf",
            "news_date": "2023-05-18 13:26:14",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March 31, 2023",
            "news_body": "Audited Financial Results For The Year Ended March 31, 2023",
            "news_id": "1cc28cd7-5dc5-4482-b46b-cbbf8d03126b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=353b5f2b-914b-4050-8ad4-758968754dd7.pdf",
            "news_date": "2023-05-18 13:17:06",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Post Results Earnings Call held on February 3, 2023",
            "news_id": "4e9344d4-badd-4ac0-8171-c54619c87b73",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c981c621-5263-4aa4-b5d7-7582cd88d42a.pdf",
            "news_date": "2023-02-10 15:18:54",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of Audio Recording of Investor Call",
            "news_id": "98b9f74a-5f6e-4820-9432-6e795af39603",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c612e6e8-f38c-4bc0-baf5-27b100b70a96.pdf",
            "news_date": "2023-02-03 20:14:21",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation on the unaudited financial results for the quarter / nine months ended on December 31, 2022.",
            "news_id": "bd56f811-7eb3-4279-92e2-5fc9cec34c92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3502cb4a-35e3-4c5d-8480-66984c88d9bd.pdf",
            "news_date": "2023-02-03 12:56:48",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Nine Months Ended On December 31, 2022",
            "news_body": "The Board of Directors at their meeting held today i.e. February 3, 2023, based on the recommendations of Audit Committee, approved the Unaudited Financial Results for the quarter / nine months ended on December 31, 2022.",
            "news_id": "30ad96c8-e90d-4ca5-a730-103cb0d604f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38badd3a-7260-45de-ba54-fb442b36e9ca.pdf",
            "news_date": "2023-02-03 12:46:16",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Nine Months Ended On December 31, 2022",
            "news_body": "The Board of Directors at their meeting held today i.e. February 3, 2023, based on the recommendations of Audit Committee, approved the Unaudited Financial Results for the quarter / nine months ended on December 31, 2022.",
            "news_id": "f45b4f4c-30c4-4b60-adc6-29efcbcfdc6d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3868823a-a378-4558-9b90-d9d94e82afa8.pdf",
            "news_date": "2023-02-03 12:44:45",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions",
            "news_body": "Related Party Transactions",
            "news_id": "b1bb32a1-f1dd-49e0-88fe-95a5cc73bf37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35c1615d-64b1-4bf5-be20-2081bd9cd27b.pdf",
            "news_date": "2022-11-25 16:33:22",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of the investor call on financial results for the quarter / half year ended on September 30, 2022",
            "news_id": "c1e88e75-c798-4e2e-8ad9-01d6f0f63aa8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01c13b5d-f8d5-4d28-b807-288092421cb7.pdf",
            "news_date": "2022-11-11 22:57:56",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for thequarter / half year ended on September 30, 2022",
            "news_id": "972d08a1-3dc6-4b60-b2b4-6f4b407026cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cbdb9ed-21d2-4bb3-b0e0-57e993701a89.pdf",
            "news_date": "2022-11-11 11:53:19",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2022",
            "news_body": "The Board of Directors at their meeting held today i.e. November 11, 2022, based on the recommendations of Audit Committee, approved the Unaudited Financial Results for the quarter / half year ended on September 30, 2022.",
            "news_id": "7686cf1c-00d0-4dfc-8caf-373bf36db6d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ab70a98-fdde-4a63-84f1-3cf54f333195.pdf",
            "news_date": "2022-11-11 11:45:06",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2022",
            "news_id": "178bcf30-136c-41ae-94dc-3ae8714807f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0a809dd-6bdb-4098-a7c5-9aad723eb2d3.pdf",
            "news_date": "2022-08-10 13:21:50",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Approval Of The Unaudited Financial Results For The Quarter Ended On June 30, 2022",
            "news_body": "Approval of the unaudited financial results for the quarter ended on June 30, 2022",
            "news_id": "22657474-e725-4d3b-a4cd-e5ee2383590d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2a0a173-7da1-4267-be05-87b05cdcdee4.pdf",
            "news_date": "2022-08-10 13:12:23",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Half Yearly Related Party Disclosure Under Regulation 23(9) Of The Listing Regulations",
            "news_body": "Half yearly Related Party Disclosure under regulation 23(9) of the Listing Regulations",
            "news_id": "5d3db77b-0de5-4901-81e0-619ae7012bb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=047744a7-6679-40e8-9864-52731a52f37d.pdf",
            "news_date": "2022-06-03 16:23:02",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The audio recording of the Company's Investor Call to discuss the financial results for the quarter and year ended March 31, 2022",
            "news_id": "875c6652-40ac-4f2f-83fb-c9ae79c4cf25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f7a26d1-7708-4ed2-b9e3-65d30670d2a1.pdf",
            "news_date": "2022-05-20 20:51:42",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "94c60e2f-a220-49d4-b493-14b9b8425434",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=494d37b5-adbf-479f-a6d4-82010e0bb4fe.pdf",
            "news_date": "2022-05-20 13:57:24",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Annual Audited Financial Results For The Financial Year Ended On March 31, 2022",
            "news_body": "Annual Audited financial results for the financial year ended on March 31, 2022",
            "news_id": "3b325595-43e9-43c6-bfd4-efa66db95755",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a99e4dc6-75a2-4dec-b775-e4ac166841ac.pdf",
            "news_date": "2022-05-20 13:28:55",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for the quarter ended on December 31, 2021",
            "news_id": "e38277ce-0368-4626-ad48-820b5af382b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6736b53-cfb4-4ae6-b910-0bf44e311898.pdf",
            "news_date": "2022-02-03 12:30:07",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Unaudited Financial Results (Standalone And Consolidated) For The Quarter / Nine Months Ended On December 31, 2021",
            "news_body": "The unaudited financial results (standalone and consolidated) for the quarter / nine months ended on December 31, 2021",
            "news_id": "a8f78c15-89ed-4895-8b51-3eb20f0f05da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aba85991-2c2a-4116-ac10-f595303ea761.pdf",
            "news_date": "2022-02-03 12:18:14",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions",
            "news_body": "The details of Related Party Transactions on consolidated basis for the half year ended on September 30, 2021",
            "news_id": "9059f2bf-d350-409e-bf42-7ee1fe13930e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=524b4c5a-f5c2-4854-bd3f-f4906c0c35a8.pdf",
            "news_date": "2021-11-26 14:38:28",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of the Company's Q2 FY22 post results conference call held at 4:00 p.m. on October 29, 2021.",
            "news_id": "e91d284a-31af-481c-94e0-92c6a5fb490b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=227e52c4-b7fb-4ea8-9dc0-03896160ad4d.pdf",
            "news_date": "2021-11-22 09:43:01",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on unaudited financial results for the quarter / half year ended September 30, 2021",
            "news_id": "2c78735f-5b65-46be-8dc5-b14c42db20f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc6a4298-fd53-4bda-a9a9-edacceb8ecc7.pdf",
            "news_date": "2021-10-29 13:01:42",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2021",
            "news_body": "Unaudited Financial Results for the quarter / half year ended on September 30, 2021",
            "news_id": "b27e7faf-1a97-42ef-b1bc-d58610cccb70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bb19c0b-0d92-487b-9b0f-bdea23693361.pdf",
            "news_date": "2021-10-29 12:12:07",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the conference call held on August 11 2021 post Q1 results",
            "news_id": "99e0a159-b534-421e-a08a-bfa7be3bf326",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da0b0954-1e8a-476c-97d5-9d01ce2fac30.pdf",
            "news_date": "2021-08-20 10:22:06",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Update on Investors Presentation",
            "news_id": "b804be61-a484-4ba7-b1c3-2af0cc781b58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ced11ddc-06d5-4d50-8745-096550fc54a0.pdf",
            "news_date": "2021-08-11 14:06:23",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2021.",
            "news_id": "4a5ef086-a9ce-4106-a8c4-018bdb3c589a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bcb376a-0c01-48f2-a950-88c70f4e8075.pdf",
            "news_date": "2021-08-11 13:39:00",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Intimation Of Unaudited Results For The Quarter Ended On June 30, 2021.",
            "news_body": "Intimation of unaudited results for the quarter ended on June 30, 2021.",
            "news_id": "efc25c90-5032-416b-883d-a80b965dfeb8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef35d45a-48d0-49d5-8ca3-b0a8fb00c346.pdf",
            "news_date": "2021-08-11 12:57:08",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Disclosure Under Regulation 23(9)",
            "news_body": "Related Party Disclosure under Regulation 23(9)",
            "news_id": "887a65b9-18ab-45d2-a0c1-13b3197e1864",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3190aa1-32e7-418d-afa0-536d63165ac5.pdf",
            "news_date": "2021-06-18 15:30:07",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March 31, 2021",
            "news_body": "Audited Financial Results for the year ended March 31, 2021",
            "news_id": "12b79e31-6d5e-46ab-8863-684a7b8e290f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1daa76e1-3654-463c-9446-035ed5a87fe4.pdf",
            "news_date": "2021-05-27 13:26:02",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "3714c038-dfe5-4118-a8f6-a423a445a1c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=056f0e90-e63c-41c9-b969-32889ddd0800.pdf",
            "news_date": "2021-05-27 13:20:29",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ZYDUSLIFE",
            "disp": "Zydus Life Science",
            "bse_code": 532321,
            "isin": "INE010B01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company is going to participate in IIFL's XII Enterprising India Conference, 2021 tomorrow i.e. 25th February, 2021.",
            "news_id": "23a008df-961c-4238-9e5c-722c987b9662",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b23f3de-09ca-4306-b62d-eee1ca2af879.pdf",
            "news_date": "2021-02-24 15:40:03",
            "seo": "cadila-healthcare-ltd",
            "ltp": 898.3,
            "ch": 11,
            "pch": 1.2397159923363013,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7929,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}